Identification and characterisation of small molecule inhibitors of feline coronavirus replication

Veterinary Microbiology

Volumn 174, Issue 3-4, 2014, Pages 438-447

  McDonagh, Phillip ^a   Sheehy, Paul A ^a   Norris, Jacqueline M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antiviral; Cats; Feline coronavirus; Feline infectious peritonitis; Feline infectious peritonitis virus; Treatment

Indexed keywords

AMILORIDE; ANTIVIRUS AGENT; ARTEMISININ; ARTESUNATE; AURINTRICARBOXYLIC ACID; BAICALIN; BAICALIN HYDRATE; CHLOROQUINE; CINANSERIN; CURCUMIN; GLYCYRRHIZIC ACID; HESPERETIN; HESPERIDIN; HEXAMETHYLENE AMILORIDE; INDOMETACIN; LACTOFERRIN; MEFLOQUINE; NICLOSAMIDE; QUERCETIN; RIBAVIRIN; RUTIN TRIHYDRATE; RUTOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; IN VITRO STUDY; NONHUMAN; VIRUS INHIBITION; VIRUS PLAQUE; VIRUS REPLICATION; ANIMAL; CAT; DRUG EFFECTS; FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS; FEMALE; GENETICS; MALE; PHYSIOLOGY; VETERINARY; VIROLOGY; VIRUS LOAD;

FELIDAE; FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS VIRUS;

ANIMALS; ANTIVIRAL AGENTS; CATS; CORONAVIRUS, FELINE; FELINE INFECTIOUS PERITONITIS; FEMALE; MALE; VIRAL LOAD; VIRUS REPLICATION;

EID: 84924070128     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.10.030     Document Type: Article

References (38)

1. Barlough J.E., Scott F.W. Effectiveness of three antiviral agents against FIP virus in vitro. Vet. Rec. 1990, 126:556-558.
2. Barlough J.E., Shacklett B.L. Antiviral studies of feline infectious peritonitis virus in vitro. Vet. Rec. 1994, 135:177-179.
3. Brickelmaier M., Lugovskoy A., Kartikeyan R., Reviriego-Mendoza M.M., Allaire N., Simon K., Frisque R.J., Gorelik L. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob. Agents Chemother. 2009, 53:1840-1849.
4. Buss N., Cammack N. Measuring the effectiveness of antiretroviral agents. Antivir. Ther. 2001, 6:1-8.
5. Dean R.T., Jessup W., Roberts C.R. Effects of exogenous amines on mammalian cells, with particular reference to membrane flow. Biochem. J. 1984, 217:27-40.
6. Dille B.J., Johnson T.C. Inhibition of vesicular stomatitis virus glycoprotein expression by chloroquine. J. Gen. Virol. 1982, 62:91-103.
7. Dutta D., Donaldson J.G. Search for inhibitors of endocytosis: intended specificity and unintended consequences. Cell. Logistics 2012, 2:203-208.
8. Fischer Y., Ritz S., Weber K., Sauter-Louis C., Hartmann K. Randomized, placebo controlled study of the effect of propentofylline on survival time and quality of life of cats with feline infectious peritonitis. J. Vet. Intern. Med. 2011, 25:1270-1276.
9. French J., Hurst N., O'Donnell M., Betts W. Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann. Rheum. Dis. 1987, 46:42-45.
10. Gazina E.V., Smidansky E.D., Holien J.K., Harrison D.N., Cromer B.A., Arnold J.J., Parker M.W., Cameron C.E., Petrou S. Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase. J. Virol. 2011, 85:10364-10374.
11. Hartmann K., Ritz S. Treatment of cats with feline infectious peritonitis. Vet. Immunol. Immunop. 2008, 123:172-175.
12. Hsieh L.E., Lin C.N., Su B.L., Jan T.R., Chen C.M., Wang C.H., Lin D.S., Lin C.T., Chueh L.L. Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus. Antivir. Res. 2010, 88:25-30.
13. Keyaerts E., Vijgen L., Maes P., Neyts J., Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem. Bioph. Res. Co. 2004, 323:264-268.
14. Keyaerts E., Vijgen L., Pannecouque C., Van Damme E., Peumans W., Egberink H., Balzarini J., Van Ranst M. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antivir. Res. 2007, 75:179-187.
15. Labro M., Babin-Chevaye C. Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob. Agents Chemother. 1988, 32:1124-1130.
16. Levi L.I., Gnädig N.F., Beaucourt S., McPherson M.J., Baron B., Arnold J.J., Vignuzzi M. Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLOS Pathog. 2010, 6:e1001163.
17. Mackenzie A.H. Pharmacologic actions of 4-aminoquinoline compounds. Am. J. Med. 1983, 75:5-10.
18. McDonagh P., Sheehy P.A., Norris J.M. In vitro inhibition of feline coronavirus replication by small interfering RNAs. Vet. Microbiol. 2011, 150:220-229.
19. McKeirnan A.J., Evermann J.F., Hargis A., Miller L.M., Ott R.L. Isolation of feline coronaviruses from two cats with diverse disease manifestations. Feline Pract. 1981, 11:16-20.
20. Mochizuki M., Nakatani H., Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet. Microbiol. 1994, 39:145-152.
21. Nevin R.L. Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis. Malar. J. 2009, 8:25-61.
22. Pedersen N.C. A review of feline infectious peritonitis virus infection: 1963-2008. J. Feline Med. Surg. 2009, 11:225-258.
23. Pham Y., Nosten F., Farinotti R., White N., Gimenez F. Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int. J. Clin. Pharm. Ther. 1999, 37:58.
24. Pussard E., Verdier F. Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics. Fund. Clin. Pharmacol. 1994, 8:1-17.
25. Ritz S., Egberink H., Hartmann K. Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis. J. Vet. Intern. Med. 2007, 21:1193-1197.
26. Rottier P.J.M., Nakamura K., Schellen P., Volders H., Haijema B.J. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J. Virol. 2005, 79:14122-14130.
27. Savarino A., Boelaert J.R., Cassone A., Majori G., Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases. Lancet Infect. Dis. 2003, 3:722-727.
28. Savarino A., Lucia M.B., Rastrelli E., Rutella S., Golotta C., Morra E., Tamburrini E., Perno C.F., Boelaert J.R., Sperber K. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J. Acquir. Immune Defic. Syndr. 2004, 35:223-232.
29. Simpson J.A., Price R., ter Kuile F., Teja-Isavatharm P., Nosten F., Chongsuphajaisiddhi T., Looareesuwan S., Aarons L., White N.J. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria&ast. Clin. Pharmacol. Ther. 1999, 66:472-484.
30. Takano T., Katada Y., Moritoh S., Ogasawara M., Satoh K., Satoh R., Tanabe M., Hohdatsu T. Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary. J. Gen. Virol. 2008, 89:1025-1029.
31. Takano T., Katoh Y., Doki T., Hohdatsu T. Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo. Antivir. Res. 2013, 99:100-107.
32. Truyen U., Blewaska S., Schultheiss U. Antiviral potency of interferon-omega (IFN-omega) against selected canine and feline viruses. Praktische Tierarzt 2002, 83:862-865.
33. Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 2006, 1:1112-1116.
34. Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G., Seidah N.G., Nichol S.T. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol. J. 2005, 2:69.
35. Weiss R.C., Cox N.R., Martinez M.L. Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis. Res. Vet. Sci. 1993, 55:162-172.
36. Weiss R.C., Oostrom-Ram T. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro. Vet. Microbiol. 1989, 20:255-265.
37. Weiss R.C., Toivio-Kinnucan M. Inhibition of feline infectious peritonitis virus replication by recombinant human leukocyte (alpha) interferon and feline fibroblastic (beta) interferon. Am. J. Vet. Res. 1988, 49:1329-1335.
38. Wilson L., Gage P., Ewart G. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication. Virology 2006, 353:294-306.